Blood Thinning Drug

Blood Thinning Drug - most related articles:

- Effient to reduce heart attack risk in angioplasty patients - 5.9
- Topical corticosteroids in children with eczema does not have negative side effects - 5.6
- Baxter's multiple-dose vial Heparin causing allergy - 3.9
- First decellularized heart valve approved in US - 3.2
- Cholesterol drug statins may reduce heart's atrial fibrillation - 2.4
- 4 drugs accounted for two thirds of emergency hospitalizations in US - 2.1
- Less medication is better to treat high blood pressure - 2.1

Blood Thinning Drug articles

Effient to reduce heart attack risk in angioplasty patients
The U.S. Food and Drug Administration has approved the Eli Lilly's blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.

Baxter's multiple-dose vial Heparin causing allergy
The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug.

2 Blood Thinning Drug articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
8.83